NAMPT and endometrial cancer: Significantly higher concentrations of visfatin have been demonstrated [73] in patients with advanced endometrial cancers, for example in cases with invasion of blood vessels, lymph node metastasis, deeper infiltration of the endometrium [73] or deeper myometrial invasion [74, 75].